Announcements Trials

Browse Landscape

Phase

Status

Unknown 9 Completed 6 Recruiting 4 Not yet recruiting 3 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Nasopharyngeal Carcinoma 1 Epstein-Barr Virus Infections 1

Interventions

Capecitabine 27 pembrolizumab 19 Oxaliplatin 19 Fluorouracil 17 Cisplatin 17 Trastuzumab 14 Docetaxel 14 Leucovorin 11 Paclitaxel 8 Irinotecan 8 S 1 (combination) 7 Epirubicin 6 Cyclophosphamide 5 tegafur-gimeracil-oteracil 4 aldesleukin 4 Hyperthermic Intraperitoneal Chemotherapy 4 titanium silicide 3 spartalizumab 3 fludarabine phosphate 3 fludarabine 3 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Ramucirumab 3 Nivolumab 3 Indocyanine Green 3 Gemcitabine 3 Carboplatin 3 Albumin-Bound Paclitaxel 3 Ado-Trastuzumab Emtansine 3 vistusertib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Stomach Neoplasms × Tegafur × Clear all

NCT00503321 2009-01-23

eNCIT-Japan

Eastern Network of Cancer Immunological Therapy, Japan

Phase 2/3 Terminated

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡